101ST GENERAL ASSEMBLY
State of Illinois
2019 and 2020
SB3092

 

Introduced 2/6/2020, by Sen. Chapin Rose

 

SYNOPSIS AS INTRODUCED:
 
410 ILCS 513/31.11 new

    Amends the Genetic Information Privacy Act. Provides that it is unlawful for any person or business to disclose an individual's genetic information to third parties specifically for marketing, advertising, or sales purposes unless the individual, or his or her legal guardian or legally authorized representative, consents in writing to the disclosure. Provides that any request for consent to disclose an individual's genetic information to third parties for marketing, advertising, or sales purposes must be provided in a written notice separate from any other communication that clearly and conspicuously states how the information will be disclosed, including to whom the information will be disclosed and how the information will be used by the recipient, seeks the individual's, or his or her legal guardian's or legally authorized representative's, consent to disclosure, and informs the individual, or his or her legal guardian or legally authorized representative, of how to cancel consent to disclosure once given.


LRB101 17666 CPF 67093 b

 

 

A BILL FOR

 

SB3092LRB101 17666 CPF 67093 b

1    AN ACT concerning health.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Genetic Information Privacy Act is amended
5by adding Section 31.11 as follows:
 
6    (410 ILCS 513/31.11 new)
7    Sec. 31.11. Uses and disclosures for marketing,
8advertising, or sales. It is unlawful for any person or
9business to disclose an individual's genetic information to
10third parties specifically for marketing, advertising, or
11sales purposes unless the individual, or his or her legal
12guardian or legally authorized representative, consents in
13writing to the disclosure. Any request for consent to disclose
14an individual's genetic information to third parties for
15marketing, advertising, or sales purposes must be provided in a
16written notice separate from any other communication that
17clearly and conspicuously states how the information will be
18disclosed, including to whom the information will be disclosed
19and how the information will be used by the recipient, seeks
20the individual's, or his or her legal guardian's or legally
21authorized representative's, consent to disclosure, and
22informs the individual, or his or her legal guardian or legally
23authorized representative, of how to cancel consent to

 

 

SB3092- 2 -LRB101 17666 CPF 67093 b

1disclosure once given.